In yet another precautionary measure during the 2012 fungal meningitis outbreak, NECC’s sister compounding pharmacy Ameridose LLC recalled all of its drugs and medical devices yesterday, according to WebMD. Though the site assured its readers that none of Ameridose’s products have been linked to fungal meningitis, Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, reportedly told the Associated Press, "We found there was not adequate assurance of sterility in their sterile products."
Despite this assertion, the recall is voluntary, Ameridose’s website stated.
“[O]ut of an abundance of caution, we are undertaking this recall to assure customers that when Ameridose products are shipped, they are fully in conformance with all of the FDA's recommendations,” the website continued.
Ameridose began operating in 2006, according to CBS. In the wake of the fungal meningitis outbreak, it shut down on October 10, so health officials could inspect the facility. It was supposed to resume operations on October 22, but that date has now been moved to November 5, per Reuters.